Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Dicoumarol | hsa00020 | Citrate cycle (TCA cycle) | 2.78E-02 | 2 | O75390, P40926 | CS, MDH2 | More | | Dicoumarol | hsa00051 | Fructose and mannose metabolism | 4.17E-02 | 2 | P15121, P60174 | AKR1B1, TPI1 | More | | Dicoumarol | hsa00052 | Galactose metabolism | 1.06E-03 | 2 | P06280, O43451 | GLA, MGAM | More | | Dicoumarol | hsa00190 | Oxidative phosphorylation | 8.71E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Dicoumarol | hsa00220 | Arginine biosynthesis | 1.36E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Dicoumarol | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.61E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Dicoumarol | hsa00310 | Lysine degradation | 4.14E-02 | 1 | Q02809 | PLOD1 | More | | Dicoumarol | hsa00500 | Starch and sucrose metabolism | 2.71E-05 | 4 | O43451, P46976, P35573, P06737 | MGAM, GYG1, AGL, PYGL | More | | Dicoumarol | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Dicoumarol | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Dicoumarol | hsa00561 | Glycerolipid metabolism | 2.51E-02 | 2 | P51648, P23743 | ALDH3A2, DGKA | More | | Dicoumarol | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | | Dicoumarol | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Dicoumarol | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Dicoumarol | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | | Dicoumarol | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.31E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Dicoumarol | hsa00730 | Thiamine metabolism | 2.53E-04 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Dicoumarol | hsa00750 | Vitamin B6 metabolism | 4.96E-02 | 1 | O00764 | PDXK | More | | Dicoumarol | hsa00830 | Retinol metabolism | 3.15E-02 | 1 | P00325 | ADH1B | More | | Dicoumarol | hsa00910 | Nitrogen metabolism | 2.61E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Dicoumarol | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.24E-03 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | | Dicoumarol | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Dicoumarol | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Dicoumarol | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Dicoumarol | hsa01100 | Metabolic pathways | 4.12E-02 | 12 | P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, P40925, P23743, P43034, P09917, Q53FZ2 | GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, MDH1, DGKA, PAFAH1B1, ALOX5, ACSM3 | More | | Dicoumarol | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.40E-02 | 1 | P50213 | IDH3A | More | | Dicoumarol | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | | Dicoumarol | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Dicoumarol | hsa03010 | Ribosome | 4.92E-05 | 11 | P42677, P30050, P40429, P46776, Q9H0U6, Q07020, P62910, P36578, P05386, P62249, P23396 | RPS27, RPL12, RPL13A, RPL27A, MRPL18, RPL18, RPL32, RPL4, RPLP1, RPS16, RPS3 | More | | Dicoumarol | hsa03013 | RNA transport | 6.43E-04 | 18 | P62826, O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, Q14152, O75822, Q13310, P20042, Q14240, Q9Y6A5, P51114 | RAN, XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF3A, EIF3J, PABPC4, EIF2S2, EIF4A2, TACC3, FXR1 | More | | Dicoumarol | hsa03015 | mRNA surveillance pathway | 4.25E-02 | 4 | Q13310, Q13362, Q15287, Q9UBU9 | PABPC4, PPP2R5C, RNPS1, NXF1 | More | | Dicoumarol | hsa03020 | RNA polymerase | 1.31E-02 | 2 | P24928, P62487 | POLR2A, POLR2G | More | | Dicoumarol | hsa03040 | Spliceosome | 5.67E-07 | 16 | O43143, O60508, P17844, P08579, P26368, P51991, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, DDX5, SNRPB2, U2AF2, HNRPA3, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Dicoumarol | hsa03410 | Base excision repair | 4.17E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Dicoumarol | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Dicoumarol | hsa04010 | MAPK signaling pathway | 1.53E-02 | 2 | Q9H2K8, Q12933 | TAOK3, TRAF2 | More | | Dicoumarol | hsa04012 | ErbB signaling pathway | 9.49E-03 | 3 | Q92529, P19174, P42338 | SHC3, PLCG1, PIK3CB | More | | Dicoumarol | hsa04014 | Ras signaling pathway | 7.65E-05 | 10 | P42338, Q92529, P20827, Q9NRA1, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, SHC3, EFNA1, PDGFC, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Dicoumarol | hsa04015 | Rap1 signaling pathway | 2.22E-03 | 9 | P20827, Q9NRA1, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, PDGFC, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Dicoumarol | hsa04020 | Calcium signaling pathway | 2.85E-04 | 10 | P27987, Q96DU7, Q08828, Q13557, P19174, P61073, P05141, P51828, Q9NRA1, P49767 | ITPKB, ITPKC, ADCY1, CAMK2D, PLCG1, CXCR4, SLC25A5, ADCY7, PDGFC, VEGFC | More | | Dicoumarol | hsa04062 | Chemokine signaling pathway | 2.01E-04 | 11 | P09769, P07948, P42338, P19174, Q92529, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Dicoumarol | hsa04064 | NF-kappa B signaling pathway | 3.99E-02 | 6 | P10415, Q13489, P29965, Q9UDY8, Q8WV28, Q13315 | BCL2, BIRC3, CD40LG, MALT1, BLNK, ATM | More | | Dicoumarol | hsa04070 | Phosphatidylinositol signaling system | 7.63E-05 | 8 | P19174, P0DP23, Q14643, P42338, P23743, Q96PE3, P27987, P17252 | PLCG1, CALM1, ITPR1, PIK3CB, DGKA, INPP4A, ITPKB, PRKCA | More | | Dicoumarol | hsa04071 | Sphingolipid signaling pathway | 1.07E-04 | 9 | P17252, Q9H228, P01375, Q13362, Q9BX95, P10415, Q9UQC2, Q12933, Q02156 | PRKCA, EDG8, TNF, PPP2R5C, SGPP1, BCL2, GAB2, TRAF2, PRKCE | More | | Dicoumarol | hsa04072 | Phospholipase D signaling pathway | 1.85E-04 | 6 | P42338, Q92529, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, SHC3, PLCG1, GNA13, DGKA, PDGFC | More | | Dicoumarol | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Dicoumarol | hsa04114 | Oocyte meiosis | 1.13E-03 | 9 | P51812, Q02750, Q13557, P16298, Q17RY0, Q08828, P51828, P27348, Q13362 | RPS6KA3, MAP2K1, CAMK2D, PPP3CB, CPEB4, ADCY1, ADCY7, YWHAQ, PPP2R5C | More | | Dicoumarol | hsa04120 | Ubiquitin mediated proteolysis | 4.82E-03 | 2 | Q9UBT2, Q14669 | SAE2, TRIP12 | More | | Dicoumarol | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Dicoumarol | hsa04145 | Phagosome | 1.59E-03 | 7 | Q15080, P14598, Q13509, P68371, Q13488, O60603, P13765 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, TLR2, HLA-DOB | More | | Dicoumarol | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Dicoumarol | hsa04151 | PI3K-Akt signaling pathway | 3.89E-06 | 28 | P62753, P42338, P43657, P25116, P27348, P20827, Q9NRA1, P49767, Q13362, P07900, P08238, Q8WYR1, P62873, P63218, P50151, P16144, O15335, Q13751, P22105, O60603, P14784, P01568, Q99941, P18848, P10415, P17252, O00141, P30281 | RPS6, PIK3CB, P2RY5, F2R, YWHAQ, EFNA1, PDGFC, VEGFC, PPP2R5C, HSP90AA1, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, ITGB4, CHAD, LAMB3, TNXB, TLR2, IL2RB, IFNA21, CREBL1, ATF4, BCL2, PRKCA, SGK, CCND3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | P06746 | POLB | DNA polymerase beta | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.74 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P06746 | POLB | DNA polymerase beta | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.859 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P06746 | POLB | DNA polymerase beta | P49767 | VEGFC | Vascular endothelial growth factor C | -0.78 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P17252 | PRKCA | Protein kinase C alpha type | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.745 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | P06746 | POLB | DNA polymerase beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.834 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P06746 | POLB | DNA polymerase beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.736 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P06746 | POLB | DNA polymerase beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.804 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P17252 | PRKCA | Protein kinase C alpha type | P16144 | ITGB4 | Integrin beta-4 | 0.755 | P06746 | POLB | DNA polymerase beta | O15335 | CHAD | Chondroadherin | -0.734 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | P17252 | PRKCA | Protein kinase C alpha type | O60603 | TLR2 | Toll-like receptor 2 | -0.716 | P06746 | POLB | DNA polymerase beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 |
| Dicoumarol | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Dicoumarol | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Dicoumarol | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Dicoumarol | hsa04217 | Necroptosis | 9.14E-03 | 7 | P01568, Q13489, P42224, Q6FI13, P10415, O43633, Q08752 | IFNA21, BIRC3, STAT1, H2AC18; H2AC19, BCL2, CHMP2A, PPID | More | | Dicoumarol | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.69E-04 | 10 | P09493, Q08828, P51828, Q99941, P18848, Q13362, P0DP23, Q13557, P17252, P10415 | TPM1, ADCY1, ADCY7, CREBL1, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2 | More | | Dicoumarol | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Dicoumarol | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Dicoumarol | hsa04370 | VEGF signaling pathway | 8.20E-05 | 5 | P19174, P16298, P42338, Q05397, Q02750 | PLCG1, PPP3CB, PIK3CB, PTK2, MAP2K1 | More | | Dicoumarol | hsa04371 | Apelin signaling pathway | 4.48E-04 | 8 | P63218, P50151, Q8WYR1, Q13370, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, PDE3B, MEF2D, GNA13, SMAD4, SMAD3 | More | | Dicoumarol | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Dicoumarol | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Dicoumarol | hsa04510 | Focal adhesion | 1.55E-02 | 5 | P42338, O15335, Q9NRA1, P49767, Q92529 | PIK3CB, CHAD, PDGFC, VEGFC, SHC3 | More | | Dicoumarol | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Dicoumarol | hsa04540 | Gap junction | 1.29E-02 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Dicoumarol | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.16E-02 | 2 | P04628, P40189 | WNT1, IL6ST | More | | Dicoumarol | hsa04611 | Platelet activation | 4.11E-02 | 3 | P42338, Q14344, P07948 | PIK3CB, GNA13, LYN | More | | Dicoumarol | hsa04612 | Antigen processing and presentation | 8.00E-04 | 8 | P04233, P25208, P26715, P26717, P10966, P01889, P10321, Q06323 | CD74, NFYB, KLRC1, KLRC2, CD8B, HLA-B, HLA-C, PSME1 | More | | Dicoumarol | hsa04613 | Neutrophil extracellular trap formation | 2.54E-03 | 11 | P17252, O60603, P08246, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P21462 | PRKCA, TLR2, ELA2, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, FPR1 | More | | Dicoumarol | hsa04622 | RIG-I-like receptor signaling pathway | 2.47E-02 | 1 | Q12933 | TRAF2 | More | | Dicoumarol | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Dicoumarol | hsa04630 | JAK-STAT signaling pathway | 3.09E-03 | 3 | O75925, P40189, Q06124 | PIAS1, IL6ST, PTPN11 | More | | Dicoumarol | hsa04640 | Hematopoietic cell lineage | 4.95E-02 | 3 | P01730, P06127, P09564 | CD4, CD5, CD7 | More | | Dicoumarol | hsa04650 | Natural killer cell mediated cytotoxicity | 2.94E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | | Dicoumarol | hsa04657 | IL-17 signaling pathway | 1.27E-03 | 5 | O00463, Q16539, P49841, P14780, P01375 | TRAF5, MAPK14, GSK3B, MMP9, TNF | More | | Dicoumarol | hsa04658 | Th1 and Th2 cell differentiation | 2.56E-05 | 8 | Q04759, P07766, P20963, P19174, P01730, P06239, P14784, Q13761 | PRKCQ, CD3E, CD247, PLCG1, CD4, LCK, IL2RB, RUNX3 | More | | Dicoumarol | hsa04659 | Th17 cell differentiation | 1.43E-06 | 12 | P25963, Q04759, P19174, P01730, P06239, P14784, P14778, P84022, Q13485, P08238, P07766, P20963 | NFKBIA, PRKCQ, PLCG1, CD4, LCK, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Dicoumarol | hsa04660 | T cell receptor signaling pathway | 2.78E-03 | 10 | Q9UDY8, Q04759, P10747, Q08881, P19174, P07766, P20963, P01730, P10966, P06239 | MALT1, PRKCQ, CD28, ITK, PLCG1, CD3E, CD247, CD4, CD8B, LCK | More | | Dicoumarol | hsa04662 | B cell receptor signaling pathway | 1.52E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Dicoumarol | hsa04664 | Fc epsilon RI signaling pathway | 1.42E-05 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Dicoumarol | hsa04666 | Fc gamma R-mediated phagocytosis | 1.73E-02 | 3 | P07948, P42338, P19174 | LYN, PIK3CB, PLCG1 | More | | Dicoumarol | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Dicoumarol | hsa04672 | Intestinal immune network for IgA production | 3.76E-03 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Dicoumarol | hsa04713 | Circadian entrainment | 2.60E-02 | 4 | P0DP23, P17252, P62873, Q14643 | CALM1, PRKCA, GNB1, ITPR1 | More | | Dicoumarol | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Dicoumarol | hsa04720 | Long-term potentiation | 1.95E-03 | 6 | P17252, P16298, P0DP23, P51812, Q02750, Q14643 | PRKCA, PPP3CB, CALM1, RPS6KA3, MAP2K1, ITPR1 | More | | Dicoumarol | hsa04722 | Neurotrophin signaling pathway | 4.87E-02 | 3 | P42338, P19174, Q92529 | PIK3CB, PLCG1, SHC3 | More | | Dicoumarol | hsa04723 | Retrograde endocannabinoid signaling | 1.88E-02 | 4 | Q14643, P17252, P62873, Q16718 | ITPR1, PRKCA, GNB1, NDUFA5 | More | | Dicoumarol | hsa04724 | Glutamatergic synapse | 1.73E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Dicoumarol | hsa04725 | Cholinergic synapse | 4.54E-06 | 11 | Q08828, P51828, Q14643, P17252, P62873, P63218, P50151, P18848, Q13557, P42338, P10415 | ADCY1, ADCY7, ITPR1, PRKCA, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, BCL2 | More | | Dicoumarol | hsa04726 | Serotonergic synapse | 3.41E-02 | 3 | P63218, P50151, P09917 | GNG5, GNG10, ALOX5 | More | | Dicoumarol | hsa04727 | GABAergic synapse | 6.57E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Dicoumarol | hsa04728 | Dopaminergic synapse | 4.76E-03 | 8 | Q14643, P17252, P62873, Q99941, P18848, Q13557, Q13362, P0DP23 | ITPR1, PRKCA, GNB1, CREBL1, ATF4, CAMK2D, PPP2R5C, CALM1 | More | | Dicoumarol | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Dicoumarol | hsa04744 | Phototransduction | 1.02E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Dicoumarol | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.77E-02 | 4 | P01584, Q08828, P51828, Q13557 | IL1B, ADCY1, ADCY7, CAMK2D | More | | Dicoumarol | hsa04910 | Insulin signaling pathway | 2.44E-03 | 6 | P22694, P06737, Q92529, Q13370, P42338, P49841 | PRKACB, PYGL, SHC3, PDE3B, PIK3CB, GSK3B | More | | Dicoumarol | hsa04911 | Insulin secretion | 6.99E-06 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Dicoumarol | hsa04912 | GnRH signaling pathway | 2.08E-04 | 7 | P17252, Q08828, P51828, P18848, Q13557, Q14643, P0DP23 | PRKCA, ADCY1, ADCY7, ATF4, CAMK2D, ITPR1, CALM1 | More | | Dicoumarol | hsa04914 | Progesterone-mediated oocyte maturation | 1.58E-03 | 6 | Q17RY0, P42338, Q13370, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, HSP90AB1, RPS6KA3, MAP2K1 | More | | Dicoumarol | hsa04915 | Estrogen signaling pathway | 3.83E-05 | 8 | Q99941, P18848, P51828, P42338, Q92529, P07900, P08238, P11142 | CREBL1, ATF4, ADCY7, PIK3CB, SHC3, HSP90AA1, HSP90AB1, HSPA8 | More | | Dicoumarol | hsa04916 | Melanogenesis | 3.73E-02 | 3 | Q13557, Q08828, P51828 | CAMK2D, ADCY1, ADCY7 | More | | Dicoumarol | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Dicoumarol | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Dicoumarol | hsa04920 | Adipocytokine signaling pathway | 4.76E-03 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | | Dicoumarol | hsa04922 | Glucagon signaling pathway | 3.47E-02 | 4 | Q12778, Q13370, P0DP23, Q14643 | FOXO1, PDE3B, CALM1, ITPR1 | More | | Dicoumarol | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | | Dicoumarol | hsa04924 | Renin secretion | 8.71E-03 | 3 | Q14643, Q13370, P0DP23 | ITPR1, PDE3B, CALM1 | More | | Dicoumarol | hsa04925 | Aldosterone synthesis and secretion | 1.18E-04 | 5 | Q99941, P18848, Q08828, P51828, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CAMK2D | More | | Dicoumarol | hsa04926 | Relaxin signaling pathway | 1.31E-04 | 8 | P42338, P63218, P50151, Q99941, P18848, P49767, P51828, Q92529 | PIK3CB, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY7, SHC3 | More | | Dicoumarol | hsa04927 | Cortisol synthesis and secretion | 3.17E-04 | 4 | Q99941, P18848, Q08828, P51828 | CREBL1, ATF4, ADCY1, ADCY7 | More | | Dicoumarol | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Dicoumarol | hsa04930 | Type II diabetes mellitus | 2.47E-02 | 1 | Q02156 | PRKCE | More | | Dicoumarol | hsa04931 | Insulin resistance | 9.16E-04 | 5 | P01375, P49841, Q06124, P06737, Q9Y478 | TNF, GSK3B, PTPN11, PYGL, PRKAB1 | More | | Dicoumarol | hsa04932 | Non-alcoholic fatty liver disease | 2.07E-02 | 5 | P18848, O75460, P01584, P12074, O15239 | ATF4, ERN1, IL1B, COX6A1, NDUFA1 | More | | Dicoumarol | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.03E-05 | 9 | P84022, Q13485, P42224, P10415, P42338, Q12778, P49767, P17252, P19174 | SMAD3, SMAD4, STAT1, BCL2, PIK3CB, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Dicoumarol | hsa04934 | Cushing syndrome | 5.27E-05 | 5 | Q99941, P18848, Q08828, P51828, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CAMK2D | More | | Dicoumarol | hsa04935 | Growth hormone synthesis, secretion and action | 1.84E-03 | 6 | P19174, P51828, Q99941, P18848, P42338, Q92529 | PLCG1, ADCY7, CREBL1, ATF4, PIK3CB, SHC3 | More | | Dicoumarol | hsa04964 | Proximal tubule bicarbonate reclamation | 2.61E-02 | 2 | P49448, P40925 | GLUD2, MDH1 | More | | Dicoumarol | hsa04966 | Collecting duct acid secretion | 2.86E-02 | 2 | Q13488, Q9Y666 | TCIRG1, SLC12A7 | More | | Dicoumarol | hsa04971 | Gastric acid secretion | 4.73E-03 | 4 | Q08828, P51828, P15311, Q13557 | ADCY1, ADCY7, VIL2, CAMK2D | More | | Dicoumarol | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | | Dicoumarol | hsa04974 | Protein digestion and absorption | 2.47E-02 | 1 | Q7Z2H8 | SLC36A1 | More | | Dicoumarol | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Dicoumarol | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Dicoumarol | hsa05010 | Alzheimer disease | 1.68E-03 | 16 | O15239, Q16718, O14521, P05496, P12074, Q14643, Q00535, O75460, P0DP23, P01584, P18848, Q13509, P68371, P05141, Q08752, P28070 | NDUFA1, NDUFA5, SDHD, ATP5G1, COX6A1, ITPR1, CDK5, ERN1, CALM1, IL1B, ATF4, TUBB3, TUBB2C, SLC25A5, PPID, PSMB4 | More | | Dicoumarol | hsa05012 | Parkinson disease | 8.40E-04 | 14 | O15239, Q16718, O14521, P12074, P05496, P05141, O75460, P18848, P28070, Q14643, P0DP23, Q13557, Q13509, P68371 | NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G1, SLC25A5, ERN1, ATF4, PSMB4, ITPR1, CALM1, CAMK2D, TUBB3, TUBB2C | More | | Dicoumarol | hsa05016 | Huntington disease | 1.72E-02 | 8 | O15239, P12074, P05496, P30876, P62487, P05141, O75460, P28070 | NDUFA1, COX6A1, ATP5G1, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4 | More | | Dicoumarol | hsa05020 | Prion disease | 1.59E-03 | 15 | P01584, P46531, O15239, Q16718, O14521, P05496, P12074, Q14643, P18848, P05141, P28070, Q13509, P68371, P14598, Q15080 | IL1B, NOTCH1, NDUFA1, NDUFA5, SDHD, ATP5G1, COX6A1, ITPR1, ATF4, SLC25A5, PSMB4, TUBB3, TUBB2C, NCF1, NCF4 | More | | Dicoumarol | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.98E-04 | 20 | Q14643, Q13509, P68371, P10415, O15239, Q16718, O14521, P12074, P05496, O75460, P18848, Q13561, P05141, P17252, Q00535, P01584, Q08752, P0DP23, Q13557, P28070 | ITPR1, TUBB3, TUBB2C, BCL2, NDUFA1, NDUFA5, SDHD, COX6A1, ATP5G1, ERN1, ATF4, DCTN2, SLC25A5, PRKCA, CDK5, IL1B, PPID, CALM1, CAMK2D, PSMB4 | More | | Dicoumarol | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Dicoumarol | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Dicoumarol | hsa05032 | Morphine addiction | 2.22E-02 | 3 | P63218, P50151, Q13370 | GNG5, GNG10, PDE3B | More | | Dicoumarol | hsa05034 | Alcoholism | 8.41E-04 | 8 | Q02930, P50151, Q9BTM1, Q93077, P62807, Q16778, O60814, P68431 | CREB5, GNG10, H2AFJ, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Dicoumarol | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | | Dicoumarol | hsa05131 | Shigellosis | 3.33E-03 | 10 | Q12933, P68431, Q02156, Q9UDY8, Q14247, Q14643, Q12778, Q13315, P10415, Q08752 | TRAF2, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, PRKCE, MALT1, CTTN, ITPR1, FOXO1, ATM, BCL2, PPID | More | | Dicoumarol | hsa05132 | Salmonella infection | 8.60E-04 | 9 | P25963, Q9UJU2, Q13489, P10415, O60603, Q9BQS8, Q13561, Q13509, P68371 | NFKBIA, LEF1, BIRC3, BCL2, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Dicoumarol | hsa05140 | Leishmaniasis | 2.17E-03 | 6 | P14598, P42224, P13765, O60603, P29350, Q15080 | NCF1, STAT1, HLA-DOB, TLR2, PTPN6, NCF4 | More | | Dicoumarol | hsa05145 | Toxoplasmosis | 1.02E-03 | 7 | P25963, P10415, Q13489, P42224, P13765, O60603, P29965 | NFKBIA, BCL2, BIRC3, STAT1, HLA-DOB, TLR2, CD40LG | More | | Dicoumarol | hsa05152 | Tuberculosis | 7.93E-04 | 8 | Q13488, P0DP23, P42224, O60603, P10415, P13765, P01568, Q9UDY8 | TCIRG1, CALM1, STAT1, TLR2, BCL2, HLA-DOB, IFNA21, MALT1 | More | | Dicoumarol | hsa05161 | Hepatitis B | 9.85E-04 | 7 | Q99941, P18848, P25963, Q13485, P10415, P27348, P84022 | CREBL1, ATF4, NFKBIA, SMAD4, BCL2, YWHAQ, SMAD3 | More | | Dicoumarol | hsa05162 | Measles | 3.91E-02 | 4 | P14784, P07766, P42338, P11142 | IL2RB, CD3E, PIK3CB, HSPA8 | More | | Dicoumarol | hsa05163 | Human cytomegalovirus infection | 8.13E-05 | 18 | P42338, P01375, P63218, P50151, Q14344, Q08828, P51828, P23458, P49841, P14778, P01584, P61073, Q13651, P25025, Q16539, P18848, O00463, P30101 | PIK3CB, TNF, GNG5, GNG10, GNA13, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, CXCR4, IL10RA, CXCR2, MAPK14, ATF4, TRAF5, PDIA3 | More | | Dicoumarol | hsa05165 | Human papillomavirus infection | 3.10E-02 | 8 | P16144, Q05086, P01568, P42224, Q13488, Q13362, Q12778, Q13315 | ITGB4, UBE3A, IFNA21, STAT1, TCIRG1, PPP2R5C, FOXO1, ATM | More | | Dicoumarol | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.34E-04 | 15 | P01568, P42224, P42338, P62873, P62879, P63218, P50151, P19174, P16298, Q14643, Q02750, P07948, P0DP23, P0CG47, Q9UJU2 | IFNA21, STAT1, PIK3CB, GNB1, GNB2, GNG5, GNG10, PLCG1, PPP3CB, ITPR1, MAP2K1, LYN, CALM1, UBB, LEF1 | More | | Dicoumarol | hsa05169 | Epstein-Barr virus infection | 4.01E-03 | 9 | P01106, P42338, P07948, O00232, P30101, Q13761, P29728, P07766, P20963 | MYC, PIK3CB, LYN, PSMD12, PDIA3, RUNX3, OAS2, CD3E, CD247 | More | | Dicoumarol | hsa05170 | Human immunodeficiency virus 1 infection | 2.49E-06 | 20 | P42338, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, Q05397, P17252, P30101, Q14643, P01568, O60603, Q13315, P19174, P07766, P10415, Q9Y6Q5, P20333 | PIK3CB, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PRKCA, PDIA3, ITPR1, IFNA21, TLR2, ATM, PLCG1, CD3E, BCL2, AP1M2, TNFRSF1B | More | | Dicoumarol | hsa05171 | Coronavirus disease - COVID-19 | 9.07E-04 | 10 | P23396, P62249, P42677, P40429, P36578, P30050, Q07020, P46776, P62910, P05386 | RPS3, RPS16, RPS27, RPL13A, RPL4, RPL12, RPL18, RPL27A, RPL32, RPLP1 | More | | Dicoumarol | hsa05200 | Pathways in cancer | 2.05E-04 | 28 | Q13751, P42338, P08238, P42224, P19174, Q9UJU2, P17252, P43246, P84022, Q13485, Q13547, P14923, P30281, P10415, Q13489, P49767, Q12778, P43657, P25116, P62873, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P01568, P14784 | LAMB3, PIK3CB, HSP90AB1, STAT1, PLCG1, LEF1, PRKCA, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, BCL2, BIRC3, VEGFC, FOXO1, P2RY5, F2R, GNB1, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IFNA21, IL2RB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P06746 | POLB | DNA polymerase beta | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.74 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P06746 | POLB | DNA polymerase beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.834 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P17252 | PRKCA | Protein kinase C alpha type | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.706 | P06746 | POLB | DNA polymerase beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.787 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P17252 | PRKCA | Protein kinase C alpha type | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.881 | P17252 | PRKCA | Protein kinase C alpha type | P17252 | PRKCA | Protein kinase C alpha type | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P17252 | PRKCA | Protein kinase C alpha type | P14923 | JUP | Junction plakoglobin | 0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P17252 | PRKCA | Protein kinase C alpha type | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.844 | P17252 | PRKCA | Protein kinase C alpha type | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.849 | P17252 | PRKCA | Protein kinase C alpha type | P49767 | VEGFC | Vascular endothelial growth factor C | 0.719 | P06746 | POLB | DNA polymerase beta | P49767 | VEGFC | Vascular endothelial growth factor C | -0.78 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P17252 | PRKCA | Protein kinase C alpha type | Q12778 | FOXO1 | Forkhead box protein O1 | 0.863 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P17252 | PRKCA | Protein kinase C alpha type | P25116 | F2R | Proteinase-activated receptor 1 | 0.857 | P17252 | PRKCA | Protein kinase C alpha type | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.852 | P06746 | POLB | DNA polymerase beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.736 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P06746 | POLB | DNA polymerase beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.804 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P06746 | POLB | DNA polymerase beta | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.75 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P17252 | PRKCA | Protein kinase C alpha type | P0DP23 | CALM1 | Calmodulin-1 | -0.776 | P17252 | PRKCA | Protein kinase C alpha type | P01568 | IFNA21 | Interferon alpha-21 | 0.733 | P06746 | POLB | DNA polymerase beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 |
| Dicoumarol | hsa05203 | Viral carcinogenesis | 5.01E-06 | 18 | Q99941, P18848, Q02930, P23458, P06746, P07948, P27348, Q7KZF4, Q15283, P06396, P12814, P01889, P10321, P61978, P06493, P62807, Q16778, O60814 | CREBL1, ATF4, CREB5, JAK1, POLB, LYN, YWHAQ, SND1, RASA2, GSN, ACTN1, HLA-B, HLA-C, HNRPK, CDK1, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Dicoumarol | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Dicoumarol | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Dicoumarol | hsa05212 | Pancreatic cancer | 4.45E-03 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Dicoumarol | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Dicoumarol | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | | Dicoumarol | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | | Dicoumarol | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | | Dicoumarol | hsa05220 | Chronic myeloid leukemia | 1.44E-03 | 6 | Q13547, Q13485, P25963, P84022, P42338, O75293 | HDAC1, SMAD4, NFKBIA, SMAD3, PIK3CB, GADD45B | More | | Dicoumarol | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Dicoumarol | hsa05226 | Gastric cancer | 6.26E-04 | 7 | Q02750, O15169, P04628, P84022, Q13485, P10415, P10826 | MAP2K1, AXIN1, WNT1, SMAD3, SMAD4, BCL2, RARB | More | | Dicoumarol | hsa05231 | Choline metabolism in cancer | 1.17E-03 | 4 | P42338, Q9NRA1, P19174, P23743 | PIK3CB, PDGFC, PLCG1, DGKA | More | | Dicoumarol | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.54E-03 | 6 | P19174, P07766, P20963, P06239, Q04759, P01730 | PLCG1, CD3E, CD247, LCK, PRKCQ, CD4 | More | | Dicoumarol | hsa05320 | Autoimmune thyroid disease | 1.27E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Dicoumarol | hsa05322 | Systemic lupus erythematosus | 4.80E-06 | 10 | P08246, P09871, P10747, P13765, P29965, Q6FI13, Q93077, P62807, O60814, P68431 | ELA2, C1S, CD28, HLA-DOB, CD40LG, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Dicoumarol | hsa05323 | Rheumatoid arthritis | 1.29E-02 | 4 | P13765, Q13488, P10747, O60603 | HLA-DOB, TCIRG1, CD28, TLR2 | More | | Dicoumarol | hsa05330 | Allograft rejection | 1.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Dicoumarol | hsa05332 | Graft-versus-host disease | 4.29E-02 | 2 | P10747, P26715 | CD28, KLRC1 | More | | Dicoumarol | hsa05340 | Primary immunodeficiency | 4.50E-02 | 3 | P01730, P07766, P06239 | CD4, CD3E, LCK | More | | Dicoumarol | hsa05415 | Diabetic cardiomyopathy | 3.55E-02 | 5 | P17252, P14598, Q15080, Q16718, O14521 | PRKCA, NCF1, NCF4, NDUFA5, SDHD | More | | Dicoumarol | hsa05416 | Viral myocarditis | 2.62E-02 | 3 | P13765, P29965, P10747 | HLA-DOB, CD40LG, CD28 | More | | Dicoumarol | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |